Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03448367 · ClinicalTrials.gov registry record
FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients
A clinical trial, sponsored by Abbott Diabetes Care.
- Terminated
- Registry status
- 19
- Enrollment target
NCT03448367 is a clinical trial that was terminated before completion, run by Abbott Diabetes Care. The registered enrollment target is 19 participants.
The verdict
NCT03448367 was terminated before completion, sponsored by Abbott Diabetes Care.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, non-randomized, single-arm, post-approval study of the FreeStyle Libre Flash Glucose Monitoring System intended to characterize the safety of the Libre Flash Glucose Monitoring System when used in pediatric patients with diabetes.
Interventions
- DEVICE FreeStyle Libre Flash Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-02-27 |
| Est. Completion | 2020-10-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03448367
The ClinicalTrials.gov registry entry for NCT03448367 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Diabetes Care, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FreeStyle Libre Flash Glucose Monitoring System is the first listed.
NCT03448367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03448367 about?
NCT03448367 is a clinical study titled "FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients". This is a prospective, multi-center, non-randomized, single-arm, post-approval study of the FreeStyle Libre Flash Glucose Monitoring System intended to characterize the safety of the Libre Flash Glucose Monitoring System when used in pediatric patients with diabetes.
What is the current status of trial NCT03448367?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2018-02-27. Estimated completion is 2020-10-13.
What interventions are being tested in trial NCT03448367?
The interventions under investigation include: FreeStyle Libre Flash Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT03448367?
This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.